Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SHE:002675)
China flag China · Delayed Price · Currency is CNY
13.52
+0.02 (0.15%)
Feb 3, 2026, 3:04 PM CST

SHE:002675 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
1,045755.97644.421,022826.61715.79
Trading Asset Securities
114.07148.5420.1227.33129.27118.04
Cash & Short-Term Investments
1,159904.51664.531,049955.88833.83
Cash Growth
21.35%36.11%-36.65%9.74%14.64%-20.35%
Accounts Receivable
987.35936.24794.08883.53875.481,005
Other Receivables
25.115.8610.9662.1319.0613.53
Receivables
1,012952.1805.04945.66894.551,018
Inventory
630.48646.22903.861,078952.53974.03
Other Current Assets
76.8364.81104.25120.0596.81118.92
Total Current Assets
2,8792,5682,4783,1932,9002,945
Property, Plant & Equipment
2,5372,3352,1471,9641,6161,286
Long-Term Investments
391.55356.05212.92191.1243.37124.71
Goodwill
2,4962,5012,5442,3302,3732,600
Other Intangible Assets
285.42252.54219.44226.06191.41192.88
Long-Term Deferred Tax Assets
111.2194.8988.0363.7158.6154.28
Long-Term Deferred Charges
423.18363.02243133.24177.03142.82
Other Long-Term Assets
162.66164.82150.3776.6996.5447.53
Total Assets
9,2858,6358,0828,1777,6567,393
Accounts Payable
578.85588.41876.021,3321,052719.08
Accrued Expenses
105.21281.49240.55255.3216.9993.07
Short-Term Debt
336.45490.23372.97391.47365.96457.06
Current Portion of Long-Term Debt
68.5464.65147.646.66156.37-
Current Portion of Leases
-9.3411.394.993.69-
Current Income Taxes Payable
105.6847.9653.4656.6136.1420.96
Current Unearned Revenue
131.33106.01114.25108.8268.4756.39
Other Current Liabilities
360.42165.87135.48197.72143.11550.44
Total Current Liabilities
1,6861,7541,9522,3932,0431,897
Long-Term Debt
347.81301.86249.21232.6520.36448.53
Long-Term Leases
157.1433.8811.077.532.89-
Long-Term Unearned Revenue
193.23196.79236.97240.2747.3361.07
Long-Term Deferred Tax Liabilities
15.6217.4118.118.6316.7618.72
Other Long-Term Liabilities
1,440959.32219.662.222.222.22
Total Liabilities
3,8403,2632,6872,8952,6332,428
Common Stock
824.6824.6824.6824.6802.21802.21
Additional Paid-In Capital
1,7711,9982,3412,4022,3172,321
Retained Earnings
1,7671,6431,6031,5171,2901,332
Comprehensive Income & Other
10.5314.846.864.84-11.7813.11
Total Common Equity
4,3734,4804,7754,7494,3974,468
Minority Interest
1,072891.02620.22533.66626.35497.33
Shareholders' Equity
5,4455,3715,3965,2825,0244,966
Total Liabilities & Equity
9,2858,6358,0828,1777,6567,393
Total Debt
909.93899.96792.23683.251,049905.6
Net Cash (Debt)
249.184.55-127.7365.7-93.39-71.77
Net Cash Growth
125.85%-----
Net Cash Per Share
0.300.01-0.150.45-0.12-0.09
Filing Date Shares Outstanding
824.6824.6824.6824.6802.21802.21
Total Common Shares Outstanding
824.6824.6824.6824.6802.21802.21
Working Capital
1,192813.69525.96799.34856.821,048
Book Value Per Share
5.305.435.795.765.485.57
Tangible Book Value
1,5921,7272,0122,1931,8331,675
Tangible Book Value Per Share
1.932.092.442.662.282.09
Buildings
-1,4901,1961,119869.32672.58
Machinery
-1,162943.15870.18747.8694.36
Construction In Progress
-567.91780.03641.37561.05409.59
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.